PRINCETON - PDS Biotechnology Corporation (NASDAQ:PDSB) has confirmed plans to commence its VERSATILE-003 Phase 3 clinical trial for a promising cancer immunotherapy within the first quarter of 2025.

In anticipation of the release of their highly awaited 22-track album, “No Song Hold On,” PDS has released another ...

We see weather headlines year round from winter to severe weather in the summer, but there is a set hierarchy to them.

A PDS gang member named Isjalon Jermiah Armstead has pled guilty to firing a weapon during a "rolling shootout" linked to ...

Robbinsville boys basketball advances past Princeton Day in the CVC Tournament with a clutch second half to set up a quarterfinal game at WW-P North ...

In the upcoming CRS issue of Radio Ink Magazine, we delve into how the Top Country Radio PDs in America view AI's role at ...